Anbio Biotechnology Class A Ordinary Shares

NNNNNASDAQHealthcare● Active

$17.57

$-5.43(-23.60%)

Market Cap$770948928

P/E Ratio—

52W High$55.65

52W Low$7.92

Avg Volume28K

Open$22.68

Beta4.34

Earnings Financials Revenue

Anbio Biotechnology Class A Ordinary Shares (NNNN) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

NNNN · earnings · updated Jun 8, 2026

Latest Earnings

Q2 FY2026Report Date: Apr 7, 2026

EPS Actual

$0.07

Revenue

$0.00B

Fiscal Period

Q2 FY2026

FY ends December

Report Date

Apr 7, 2026

After Market Close

NNNN reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Rev. $0.58B

Days Away85

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

Rev. Est.$0.58B

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q2 FY2026	Apr 7, 2026	—	$0.07	—	$0.00B	—	—

Q2 FY2026

Apr 7, 2026

EPS Actual

$0.07

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

No analyst estimates available for NNNN.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2026	Apr 7, 2026	—	$26.15	$27.37	+4.67%

Q2 FY2026+4.67%

Report Date

Apr 7, 2026

EPS Beat/Miss

—

Price Before

$26.15

Price After

$27.37

Beat Rate0 / 1 quarters

Largest Move+4.67% (Q2 FY2026)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Anbio Biotechnology Class A Ordinary Shares (NNNN) most recently reported earnings on April 7, 2026 for Q2 FY2026, posting EPS of $0.07 (in line with the analyst consensus of —). The next NNNN earnings date is expected around September 1, 2026.

Each quarter, investors track NNNN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NNNN revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

NNNN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

NNNN earnings · 4 questions

Anbio Biotechnology Class A Ordinary Shares's next earnings report is expected around September 1, 2026. NNNN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NNNN historically reports after market close (AMC).

NNNN earnings datewhen is NNNN earningsNNNN next earnings datewhen does NNNN report earningsNNNN earnings calendar

▸ Source: FMP · Anbio Biotechnology Class A Ordinary Shares SEC filings · US GAAP · Anbio Biotechnology Class A Ordinary Shares SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026